SUSANN MISCHKE: Open Payments
NPI 1366067449 · SANTA ROSA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$977 in 31 payments from 16 companies in 2025. Trend: 2023 $1,012 · 2024 $1,080 · 2025 $977
Food & beverage: $977
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 7 | $186 |
| Boston Scientific Corporation | 3 | $186 |
| Medtronic, Inc. | 2 | $183 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $83 |
| Amgen Inc. | 2 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Edwards Lifesciences Corporation | 1 | $26 |
| PFIZER INC. | 1 | $25 |
Products named: WATCHMAN FLX, MICRA, VERQUVO, WINREVAIR, Repatha, LEQVIO, SYMPLICITY G3, PASCAL.
Industry payments across CA — which companies pay providers there.
